Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|July 5, 2022
[New trend in genotoxicity research taking into account genome instability]Kei-Ichi Sugiyama, Kenichi Masumura
Genes and Environment : the Official Journal of the Japanese Environmental Mutagen Society|February 9, 2017
Transgenic rat models for mutagenesis and carcinogenesisTakehiko Nohmi, Kenichi Masumura, Naomi Toyoda-Hokaiwado
Genes and Environment : the Official Journal of the Japanese Environmental Mutagen Society|June 4, 2020
Effects of the <i>scid</i> mutation on X-ray-induced deletions in the brain and spleen of <i>gpt</i> delta miceKenichi Masumura, Fumio Yatagai, Masako Ochiai, et al.
Toxicology|July 23, 2014
Genotoxicity of phenacetin in the kidney and liver of Sprague-Dawley gpt delta transgenic rats in 26-week and 52-week repeated-dose studiesYuji Kawamura, Hiroyuki Hayashi, Kenichi Masumura, et al.
Food Safety (Tokyo, Japan)|January 31, 2020
Mutant Frequency is not Increased in Mice Orally Exposed to Sodium DichromateYasunobu Aoki, Michiyo Matsumoto, Michi Matsumoto, et al.
Mutation Research|June 28, 2011
Involvement of mismatch repair proteins in adaptive responses induced by N-methyl-N'-nitro-N-nitrosoguanidine against γ-induced genotoxicity in human cellsAyumi Yamamoto, Yasuteru Sakamoto, Kenichi Masumura, et al.
Regulatory Toxicology and Pharmacology : RTP|May 5, 2025
Verification of health-based guidance values for carbendazimTakako Iso, Takaaki Umano, Kei-Ichi Sugiyama, et al.
Genes and Environment : the Official Journal of the Japanese Environmental Mutagen Society|June 29, 2016
Genomic integration of lambda EG10 transgene in gpt delta transgenic rodentsKenichi Masumura, Yasuteru Sakamoto, Wakako Kumita, et al.
Toxicology|August 3, 2013
Evaluation of the genotoxicity of tamoxifen in the liver and kidney of F344 gpt delta transgenic rat in 3-week and 13-week repeated dose studiesYuji Kawamura, Hiroyuki Hayashi, Yasushi Kurata, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|May 6, 2026
[Evaluating the Validity of the Action Limit and Predicted Environmental Concentration (PEC) in Environmental Risk Assessment Guidance for Novel Human Pharmaceuticals in Japan]Shigechika Yamamoto, Taeko Maruyama-Komoda, Kenichi Masumura, et al.
Pageof 6